title: Relevance of apolipoprotein E4 for the lipid profile of Brazilian patients with coronary artery disease.
abstract: Apolipoprotein E (apoE - e2, e3, e4 alleles) plays a role in the regulation of lipid metabolism, with the e4 considered to be a risk factor for coronary artery disease (CAD). We aimed to evaluate the apoE polymorphisms in Brazilians with CAD and their influence on the lipid profile and other risk factors (hypertension, diabetes mellitus, smoking). Two hundred individuals were examined: 100 patients with atherosclerosis confirmed by coronary angiography and 100 controls. Blood samples were drawn to determine apoE polymorphisms and lipid profile. As expected, the e3 allele was prevalent in the CAD (0.87) and non-CAD groups (0.81; P = 0.099), followed by the e4 allele (0.09 and 0.14, respectively; P = 0.158). The e3/3 (76 and 78%) and e3/4 (16 and 23%) were the most common genotypes for patients and controls, respectively. The lipid profile was altered in patients compared to controls (P < 0.05), independently of the e4 allele. However, in the controls this allele was prevalent in individuals with elevated LDL-cholesterol levels only (odds ratio = 2.531; 95% CI = 1.028-6.232). The frequency of risk factors was higher in the CAD group (P < 0.05), but their association with the lipid profile was not demonstrable in e4 carriers. In conclusion, the e4 allele is not associated with CAD or lipid profile in patients with atherosclerosis. However, its frequency in the non-CAD group is associated with increased levels of LDL-cholesterol, suggesting an independent effect of the e4 allele on lipid profile when the low frequency of other risk factors in this group is taken into account.
authors.affiliation: Departamento de Biologia Molecular, Faculdade de Medicina de São José do Rio Preto, Avenida Brigadeiro Faria Lima 5416, 15090-000 São José do Rio Preto, SP, Brazil. doroteia@famerp.br
authors.forename: D R S
authors.initials: DR
authors.lastname: Souza
authors.forename: L
authors.initials: L
authors.lastname: Nakachima
authors.forename: R B
authors.initials: RB
authors.lastname: Biagioni
authors.forename: M A
authors.initials: MA
authors.lastname: Nakazone
authors.forename: M A S
authors.initials: MA
authors.lastname: Pinhel
authors.forename: D M
authors.initials: DM
authors.lastname: Trindade
authors.forename: V T
authors.initials: VT
authors.lastname: Mafra
authors.forename: L H B
authors.initials: LH
authors.lastname: Tácito
authors.forename: J F V
authors.initials: JF
authors.lastname: Martin
authors.forename: S
authors.initials: S
authors.lastname: Pinheiro Júnior
authors.forename: A C
authors.initials: AC
authors.lastname: Brandão
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D001057:Apolipoproteins E / Q000235:genetics*; D016022:Case-Control Studies; D003324:Coronary Artery Disease / Q000097:blood* / Q000235:genetics; D005260:Female; D005838:Genotype; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D012307:Risk Factors
chemical_list: D001057:Apolipoproteins E; D008055:Lipids